Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:44 PM
Ignite Modification Date:
2025-12-24 @ 3:44 PM
NCT ID:
NCT06996392
Eligibility Criteria:
Inclusion Criteria:
* Age between 18 and 65 years, irrespective of gender.
* Patients with acute-on-chronic liver failure, diagnosed according to the - - Guideline for diagnosis and treatment of liver failure (2024 version) in China.
* Subjects must provide informed consent prior to the study and voluntarily sign the written informed consent form.
* Subjects must be able to communicate effectively with the investigators and comply with the study protocol.
Exclusion Criteria:
* Active bleeding or disseminated intravascular coagulation (DIC) that is not effectively controlled.
* Allergies to the blood products or medications used during treatment.
* Circulatory failure.
* Occurrence of myocardial infarction, cerebral infarction, or cerebral hemorrhage within the past 6 months.
* A history of malignant tumors within the past 5 years (except for cured basal cell carcinoma of the skin or carcinoma in situ of the cervix).
* Any other conditions that, in the opinion of the investigator, render the subject unsuitable for participation in the study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT06996392
Study Brief:
Protocol Section:
NCT06996392